Story
Drägerwerk Stock Climbs After Boosting 2026 Profitability Outlook
Summary
Shares in the German medical and safety technology group rose after it reported preliminary Q2 sales that beat expectations and raised the lower end of its full-year profit margin forecast.
Shares of Drägerwerk (ETR: DRWG) gained 2.5% to reach €73 in Tuesday trading after the company released better-than-expected preliminary second-quarter results and upgraded its full-year profitability guidance.
Preliminary Results Exceed Forecasts
Drägerwerk reported a strong operational performance for the second quarter and first half of 2026. The company's preliminary figures showed a significant top-line beat and a substantial increase in operating profit.
- Q2 Currency-Adjusted Net Sales: Rose 8.5% year-over-year to approximately €847 million, surpassing analyst forecasts of around €820 million.
- H1 2026 EBIT: More than tripled to about €64 million, a sharp increase from the €20.4 million recorded in the same period a year earlier.
Both of the company's main divisions, Medical Technology and Safety Technology, contributed to the growth, with each segment expanding by approximately 7–8% on a currency-adjusted basis in the first half of the year, according to the release.
Upgraded Full-Year Guidance
AdBuoyed by the strong results, Drägerwerk's management raised its profitability outlook for the full year. The company lifted the lower end of its expected EBIT margin range by half a percentage point.
The new guidance calls for a full-year 2026 EBIT margin between 5.5% and 7.5%. The company attributed the improved forecast to a combination of strong operational execution and the positive impact of tariff refunds.
Market Context
Drägerwerk's advance was driven by company-specific news, standing in contrast to the broader market trend on Tuesday. The German DAX index was trading under pressure, and other European indices were flat to slightly negative.
Investor sentiment in the wider market was dampened by a sharp rise in oil prices, which fueled inflation concerns ahead of key U.S. consumer price data. Drägerwerk's positive update provided a compelling reason for investors to bid up the stock despite the lack of a macroeconomic tailwind.
Read next
More on Stocks
U.S. Stock Futures Rebound as Markets Digest Hawkish Fed Rate Hike
U.S. stock futures rose in overnight trading, recovering from a sell-off triggered by the Federal Reserve's first interest rate hike in three years. Falling oil prices and positive corporate news helped lift market sentiment.
Holtec Suspends $900 Million IPO Amid Challenging Market Conditions
Nuclear services company Holtec Nuclear Corp. has postponed its U.S. initial public offering, which aimed to raise as much as $900 million, citing unfavorable market conditions and weak performance from recently listed peers in the sector.
Snap Stock Climbs on Enterprise Push for New Specs AR Glasses
Shares of Snap Inc. gained in after-hours trading after the company unveiled its new $2,195 Specs AR glasses and announced key enterprise partnerships with Salesforce, Nvidia, and AWS.
Gold Prices Fall as Hawkish Fed Outlook Boosts US Dollar
Gold prices declined after the Federal Reserve raised interest rates by 25 basis points and signaled further tightening, strengthening the U.S. dollar and increasing the opportunity cost of holding the non-yielding metal.